Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Singular Health Group Ltd ( (AU:SHG) ) is now available.
Singular Health Group Limited reported a significant decline in revenues by 83% for the year ending June 30, 2025, compared to the previous year, alongside a 29% increase in net losses. The company gained control over Singular 3DiCom Solutions USA Pty Ltd but lost control of Singular 3DP Pty Ltd. Despite the financial downturn, the company’s net tangible assets per ordinary security increased, indicating a potential shift in asset management or valuation.
The most recent analyst rating on (AU:SHG) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.
More about Singular Health Group Ltd
Singular Health Group Limited operates in the healthcare technology industry, focusing on developing advanced software solutions for medical imaging and 3D printing. The company is known for its innovative products aimed at enhancing medical diagnostics and treatment planning.
Average Trading Volume: 902,306
Technical Sentiment Signal: Buy
Current Market Cap: A$98.95M
Learn more about SHG stock on TipRanks’ Stock Analysis page.